Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics.
Kamal MA, Smith PF, Chaiyakunapruk N, Wu DBC, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Kirkpatrick CM, Rayner CR. Kamal MA, et al. Among authors: smith pf. Br J Clin Pharmacol. 2017 Jul;83(7):1580-1594. doi: 10.1111/bcp.13229. Epub 2017 Feb 20. Br J Clin Pharmacol. 2017. PMID: 28176362 Free PMC article.
Assessing the Combined Public Health Impact of Pharmaceutical Interventions on Pandemic Transmission and Mortality: An Example in SARS CoV-2.
Kamal MA, Kuznik A, Qi L, Więcek W, Hussein M, Hassan HE, Patel K, Obadia T, Toroghi MK, Conrado DJ, Al-Huniti N, Casciano R, O'Brien MP, Barnabas RV, Cohen MS, Smith PF. Kamal MA, et al. Among authors: smith pf. Clin Pharmacol Ther. 2022 Dec;112(6):1224-1235. doi: 10.1002/cpt.2728. Epub 2022 Sep 20. Clin Pharmacol Ther. 2022. PMID: 35984050 Free PMC article.
Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization.
Sturm S, Lemenuel-Diot A, Patel K, Gibiansky L, Bhardwaj R, Smith PF, Dang S, Zwanziger E, Nasmyth-Miller C, Ravva P. Sturm S, et al. Among authors: smith pf. Br J Clin Pharmacol. 2021 Mar;87(3):1359-1368. doi: 10.1111/bcp.14523. Epub 2020 Sep 9. Br J Clin Pharmacol. 2021. PMID: 32808306 Free PMC article.
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.
Rayner CR, Smith PF, Andes D, Andrews K, Derendorf H, Friberg LE, Hanna D, Lepak A, Mills E, Polasek TM, Roberts JA, Schuck V, Shelton MJ, Wesche D, Rowland-Yeo K. Rayner CR, et al. Among authors: smith pf. Clin Pharmacol Ther. 2021 Apr;109(4):867-891. doi: 10.1002/cpt.2198. Epub 2021 Mar 9. Clin Pharmacol Ther. 2021. PMID: 33555032 Free PMC article. Review.
Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics.
Wu DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Smith PF, Kirkpatrick CM, Kamal MA, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Rayner CR. Wu DBC, et al. Among authors: smith pf. Epidemiol Infect. 2018 Mar;146(4):496-507. doi: 10.1017/S0950268818000158. Epub 2018 Feb 15. Epidemiol Infect. 2018. PMID: 29446343 Free PMC article.
Optimizing COVID-19 Candidate Therapeutics: Thinking Without Borders.
Rayner CR, Smith PF, Hershberger K, Wesche D. Rayner CR, et al. Among authors: smith pf. Clin Transl Sci. 2020 Sep;13(5):830-834. doi: 10.1111/cts.12790. Epub 2020 May 2. Clin Transl Sci. 2020. PMID: 32212378 Free PMC article. No abstract available.
638 results